Chemotherapy SpecialistsPage 5

Jennifer Ligibel, MD

Professor at Harvard Medical School and a Senior Physician in the Breast Oncology Center at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on; Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living and has built a comprehensive clinical Healthy Living Program for patient

Oncology

Sarat Chandarlapaty, M.D., PH.D.

Breast Medical Oncologist; Naddisy Foundation Chair in Breast Cancer Research at Memorial Sloan Kettering; Section Head for Translational Research, Breast Service, Department of Medicine; Director, Developmental Research Program, MSK Breast SPORE; Member and Lab Head, Human Oncology and Pathogenesis Program

Oncology

Matthew Goetz, M.D.

Director, Mayo Breast Cancer Specialized Program of Research Excellence

Oncology

Tanguy Seiwert, M.D.

Director, Head and Neck Cancer Oncology Disease Program; Co-Director, Bloomberg~Kimmel Institute for Immunotherapy; Assistant Professor of Oncology, Johns Hopkins University School of Medicine

Oncology

Samuel Denmeade, M.D.

R. Dale Hughes Professor of Oncology and Director, Genitourinary Oncology Program, Johns Hopkins University School of Medicine

Oncology

Ravi Vij, MD

Oncology

Bruce Johnson, MD

Professor Emeritus of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute

Oncology

David Solit, MD

Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology; Attending Physician, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center

Oncology

Kevin Kalinsky, M.D.

Professor and Director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Director, Glenn Family Breast Center; Louisa and Rand Glenn Family Chair in Breast Cancer Research; Director, Breast Medical Oncology, Winship Cancer Institute of Emory University

Oncology

Robert Dreicer, M.D.

Deputy Director, UVA Comprehensive Cancer Center; Associate Director for Clinical Research; Professor of Medicine and Urology; Director, Solid Tumor Oncology; Section Head of Medical Oncology; Co-Director, Paul Mellon Urologic Institute

Oncology

Ajay Gopal, MD

Professor, Division of Hematology and Oncology, University of Washington; Professor, Clinical Research Division, Fred Hutch Cancer Center; Director of Clinical Research, Hematologic Malignancies/Hematology, Fred Hutch / UW Cancer Consortium; Stephen H. Petersdorf Endowed Chair in Cancer Care

Oncology

David Ettinger, M.D.

Alex Grass Professor of Oncology, Professor of Medicine, Otolaryngology-Head and Neck Surgery, Gynecology and Obstetrics, and Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine

Oncology

Ellen Ritchie, MD

Associate Professor of Clinical Medicine, Weill Cornell Medical College

Oncology

Alan Venook, MD

Madden Family Distinguished Professor of Medical Oncology and Translational Research; Shorenstein Associate Director for Program Development, Helen Diller Family Comprehensive Cancer Center; Professor, Department of Medicine (Hematology/Oncology)

Oncology

Jordan Berlin, MD

Professor of Medicine (Hematology/Oncology); Director, Division of Hematology and Oncology; Associate Director for Clinical Research, Vanderbilt-Ingram Cancer Center; Director, Phase I Program; Ingram Professor of Cancer Research; Cornelius Abernathy Craig Professor of Medicine

Oncology

Tina Cascone, M.D., PH.D.

Section Chief, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; Associate Professor, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Oncology

David Hong, M.D.

Professor (tenure), Department of Investigational Cancer Therapeutics, Division of Cancer Medicine; Deputy Chair, Department of Investigational Cancer Therapeutics

Oncology

Nuhad Ibrahim, M.D.

Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Oncology

Ann Partridge, MD MPH

Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you

Oncology

Christopher Logothetis, M.D.

Professor, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center

Oncology